Assessing adolescent kidney health in a Chronic Kidney Disease of Uncertain origin (CKDU) endemic region in India Dr Deepthi N Shanbhag Dr Niveditha Kamath (Paed Nephrology)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - Ongoing
Project Lead
Authors
Dr Deepthi N Shanbhag Dr Niveditha Kamath
Project Status
ongoing